Cargando…

Invariant NKT cells as a platform for CAR immunotherapy and prevention of acute Graft-versus-Host Disease

Detalles Bibliográficos
Autores principales:	Karadimitris, Anastasios, Ripoll-Fiol, Carme, Guerra, Jose Costa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Cellular and gene therapy - Section 4
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925712/ https://www.ncbi.nlm.nih.gov/pubmed/35309781 http://dx.doi.org/10.1097/HS9.0000000000000220

Ejemplares similares

Mechanisms of action for different checkpoint inhibitors
por: Berraondo, Pedro
Publicado: (2019)

CAR NK-92 cell–mediated depletion of residual TCR(+) cells for ultrapure allogeneic TCR-deleted CAR T-cell products
por: Kath, Jonas, et al.
Publicado: (2023)

Prognostic plasma biomarkers of early complications and graft‐versus‐host disease in patients undergoing allogeneic hematopoietic stem cell transplantation
por: Balakrishnan, Balaji, et al.
Publicado: (2020)

Cellular and gene therapy
por: Padua, Rose Ann
Publicado: (2019)

CAR-iNKT cells targeting clonal TCRVβ chains as a precise strategy to treat T cell lymphoma
por: Rowan, Aileen G., et al.
Publicado: (2023)

Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
por: Hernani, Rafael, et al.
Publicado: (2021)

Overexpression of RANKL by invariant NKT cells enriched in the bone marrow of patients with multiple myeloma
por: Spanoudakis, E, et al.
Publicado: (2016)

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
por: Pilones, Karsten A., et al.
Publicado: (2012)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
por: Wolf, Benjamin J., et al.
Publicado: (2018)

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
por: Carlisle, Robert C., et al.
Publicado: (2009)

AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage
por: Binny, Christopher, et al.
Publicado: (2012)

Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells
por: Zhang, Fang, et al.
Publicado: (2007)

CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells
por: Flynn, Rowan, et al.
Publicado: (2015)

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
por: Strati, Paolo, et al.
Publicado: (2021)

Pharmacokinetic analysis identifies a factor VIII immunogenicity threshold after AAV gene therapy in hemophilia A mice
por: Lundgren, Taran S., et al.
Publicado: (2022)

Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
por: Ghione, Paola, et al.
Publicado: (2022)

In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently overexpressing cxcr4
por: Wang, Hongjie, et al.
Publicado: (2022)

Transcutaneous ultrasound-mediated gene delivery into canine livers achieves therapeutic levels of factor VIII expression
por: Manson, Megan A., et al.
Publicado: (2022)

CD14(+)/CD31(+) monocytes expanded by UM171 correct hemophilia A in zebrafish upon lentiviral gene transfer of factor VIII
por: Elnaggar, Muhammad, et al.
Publicado: (2022)

In vivo HSC prime editing rescues sickle cell disease in a mouse model
por: Li, Chang, et al.
Publicado: (2023)

Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells
por: Vavassori, Valentina, et al.
Publicado: (2023)

Adenine base editor–mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation
por: Hardouin, Giulia, et al.
Publicado: (2023)

Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy
por: von Drygalski, Annette, et al.
Publicado: (2022)

Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing
por: Sun, Zhengxu, et al.
Publicado: (2023)

A comprehensive landscape of transcription profiles and data resources for human leukemia
por: Luo, Mei, et al.
Publicado: (2023)

Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci in mice
por: Calabria, Andrea, et al.
Publicado: (2023)

Sars-Cov-2 Infections in CAR T Cell Recipients
por: McNerney, Kevin O., et al.
Publicado: (2021)

Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming
por: Simonetta, Federico, et al.
Publicado: (2021)

iNKT: A new avenue for CAR-based cancer immunotherapy
por: Liu, Yilin, et al.
Publicado: (2022)

RUNX inhibitor suppresses graft‐versus‐host disease through targeting RUNX‐NFATC2 axis
por: Kubota, Hirohito, et al.
Publicado: (2021)

CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
por: Hadiloo, Kaveh, et al.
Publicado: (2023)

Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting
por: Rotolo, Antonia, et al.
Publicado: (2018)

Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
por: Aoki, Takahiro, et al.
Publicado: (2023)

The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON‐107 study
por: de Greef, Georgine E., et al.
Publicado: (2018)

CT-107: Coronavirus Disease in Bone Marrow Transplant (BMT) Recipients at Edgardo Rebagliati Martins Hospital (HNERM) Lima, Peru
por: Bazan, Susy, et al.
Publicado: (2021)

Immune reconstitution following umbilical cord blood transplantation: IRES, a study of UK paediatric patients
por: Girdlestone, John, et al.
Publicado: (2020)

Poster: CT-128 Simple Prognostic Markers in Patients With Hematological Malignancies and COVID-19 Infection: Single-Center Experience
por: Rakha, Nahed Moawad, et al.
Publicado: (2022)

CT-157 Another Rare Case of COVID-19 Vaccine Induced Acquired Hemophilia
por: Ismail, Asmaa M.
Publicado: (2022)

CT-128 Simple Prognostic Markers in Patients With Hematological Malignancies and COVID-19 Infection: Single-Center Experience
por: Rakha, Nahed Moawad, et al.
Publicado: (2022)

Single step method for high yield human platelet lysate production
por: Delabie, Willem, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b6rcb1496io16oct2htp3hrh54